Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Allogene Therapeutics Q2 EPS $(0.53) Beats $(0.55) Estimate, Sales $44.00K


Benzinga | Aug 4, 2021 04:52PM EDT

Allogene Therapeutics Q2 EPS $(0.53) Beats $(0.55) Estimate, Sales $44.00K

Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.55) by 3.64 percent. This is unchanged from the same period last year. The company reported $44.00 thousand in sales this quarter.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC